Blueprint Medicines
Blueprint Medicines Logo
About Blueprint Medicines
Blueprint Medicines Corporation is a biopharmaceutical company focused on developing precision therapies for genomically defined cancers and blood disorders. The company researches, develops, and commercializes targeted medicines, including AYVAKIT for systemic mastocytosis and gastrointestinal stromal tumors, and GAVRETO for RET fusion-positive cancers. Blueprint Medicines also advances a pipeline of therapies for various cancer types and rare diseases, aiming to address the underlying molecular drivers of disease. The company collaborates with global partners to expand the reach of its innovative treatments.
Address
45 Sidney Street,
Cambridge, 02139
United States
Year founded
2008
Number of employees
600-700
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
